|
Volumn 132, Issue 2, 2002, Pages 149-156
|
Targeted gene therapy with CD40Ig to induce long-term acceptance of liver allografts
a a a a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
CD40 ANTIGEN;
CD40 LIGAND;
CD40IG ANTIGEN;
IMMUNOGLOBULIN FC FRAGMENT;
IMMUNOGLOBULIN G2A;
UNCLASSIFIED DRUG;
ADENOVIRUS;
ALLOGRAFT;
ANIMAL CELL;
ANIMAL EXPERIMENT;
ANIMAL MODEL;
ANIMAL TISSUE;
ANTIGEN PRESENTING CELL;
ARTICLE;
CONTROLLED STUDY;
GENE EXPRESSION;
GENE THERAPY;
GENE TRANSFER;
GENETIC TRANSDUCTION;
GRAFT SURVIVAL;
IMMUNE RESPONSE;
IMMUNOGLOBULIN BLOOD LEVEL;
LIVER TRANSPLANTATION;
LYMPHOCYTIC INFILTRATION;
MALE;
NONHUMAN;
PRIORITY JOURNAL;
PROTEIN DOMAIN;
RAT;
REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;
SKIN TRANSPLANTATION;
T LYMPHOCYTE;
TRANSGENE;
VIRUS PARTICLE;
VIRUS RECOMBINANT;
|
EID: 0036673417
PISSN: 00396060
EISSN: None
Source Type: Journal
DOI: 10.1067/msy.2002.125169 Document Type: Article |
Times cited : (12)
|
References (25)
|